Susceptibility to Crohn's disease, a complex inflammatory disease involving the small intestine, is controlled by over 30 loci 1 . One Crohn's disease risk allele is in ATG16L1, a gene homologous to the essential yeast autophagy gene ATG16 (ref. 2). It is not known how ATG16L1 or autophagy contributes to intestinal biology or Crohn's disease pathogenesis. To address these questions, we generated and characterized mice that are hypomorphic for ATG16L1 protein expression, and validated conclusions on the basis of studies in these mice by analysing intestinal tissues that we collected from Crohn's disease patients carrying the Crohn's disease risk allele of ATG16L1. Here we show that ATG16L1 is a bona fide autophagy protein. Within the ileal epithelium, both ATG16L1 and a second essential autophagy protein ATG5 are selectively important for the biology of the Paneth cell, a specialized epithelial cell that functions in part by secretion of granule contents containing antimicrobial peptides and other proteins that alter the intestinal environment 3 . ATG16L1-and ATG5-deficient Paneth cells exhibited notable abnormalities in the granule exocytosis pathway. In addition, transcriptional analysis revealed an unexpected gain of function specific to ATG16L1-deficient Paneth cells including increased expression of genes involved in peroxisome proliferator-activated receptor (PPAR) signalling and lipid metabolism, of acute phase reactants and of two adipocytokines, leptin and adiponectin, known to directly influence intestinal injury responses. Importantly, Crohn's disease patients homozygous for the ATG16L1 Crohn's disease risk allele displayed Paneth cell granule abnormalities similar to those observed in autophagy-protein-deficient mice and expressed increased levels of leptin protein. Thus, ATG16L1, and probably the process of autophagy, have a role within the intestinal epithelium of mice and Crohn's disease patients by selective effects on the cell biology and specialized regulatory properties of Paneth cells.
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Crohn's disease typically involves the distal ileum and in its most severe form is characterized by pathological changes including transmural acute and chronic inflammation. Crohn's disease is associated with increased expression of immunoregulatory cytokines including leptin 4 and adiponectin 5 . Multiple genetic factors predispose to Crohn's disease, but the specific relationship between the function of these genes and the diverse pathologies observed in Crohn's disease is not well understood. One Crohn's disease susceptibility allele is in the predicted autophagy gene ATG16L1 (refs 6-9) . Autophagy is an evolutionarily conserved process that recycles cellular components by means of delivery of double-membrane-bound vesicles containing cytoplasm and cytoplasmic organelles to the lysosome 10 . Autophagy has an important role in cell and tissue homeostasis, and has been implicated in a range of human diseases 10 . The mammalian ATG16L1 protein contains an amino-terminal domain that is homologous to yeast Atg16 (ref. 2) , which functions in autophagy as part of a complex with autophagy proteins Atg5 and Atg12 (refs 2, 11). Atg16 is responsible, in yeast and mammalian cells, for proper subcellular localization of the autophagy machinery 8, 11, 12 .
To determine the role of ATG16L1 and autophagy in the intestine, we generated two mouse lines with gene-trap-mediated disruptions of Atg16l1 and a third line lacking Atg5 in intestinal epithelial cells. Gene-trap vectors introduce a false splice acceptor into an intron, and can inhibit expression of intact messenger RNA 13 ( Fig. 1a) . This can result in decreased expression of a protein, potentially generating viable mice when full disruption of a gene is lethal. This approach is attractive because ATG5 is part of the ATG16L1 complex and full disruption of Atg5 is lethal 2, 14 . Mouse lines homozygous for gene-trap mutations were generated from commercially available embryonic stem cells carrying gene-trap mutations in the intron 39 to either exon 6 or exon 10 of Atg16l1 (ref. 13 ). Atg16l1 mutant mouse embryonic fibroblasts (MEFs) expressed low levels of ATG16L1 protein (Fig. 1b) indicating that both mouse lines, ATG16L1
HM1 and ATG16L1 HM2 , are hypomorphic (HM) for expression of the ATG16L1 protein.
ATG16L1
HM mice were born at Mendelian ratios ( Supplementary  Fig. 1a ) and survive to adulthood; the characteristics of the two ATG16L1 HM lines in vivo were similar across all experiments. To determine whether ATG16L1 is an autophagy protein, we studied low-passage and transformed MEFs from ATG16L1 HM mice compared to MEFs lacking the essential autophagy protein ATG5 (ref. 14) . Rapamycin-induced and autophagy-dependent 15 degradation of the adaptor protein sequestosome (SQSTM1, also known as P62) was diminished in ATG16L1 HM and Atg5 2/2 cells (Fig. 1c-e) . Decreased degradation of P62 in ATG16L1 HM cells was restored by expressing ATG16L1 (Supplementary Fig. 1b, c) . ATG16L1
HM MEFs also showed diminished rapamycin-induced production of LC3-II, the phosphatidylethanolamine-conjugated form of microtubuleassociated protein 1 light chain 3 (LC3-I) generated during autophagy 10 ( Fig. 1e, f) . The induction of autophagosomes, as measured by LC3-positive dot formation after rapamycin treatment or starvation, was also decreased in ATG16L1 HM MEFs ( Supplementary Fig. 2 ), although the defect of ATG16L1 HM2 cells was more subtle in starved cells; this was confirmed in cells transfected with green fluorescent protein (GFP)-LC3 ( Supplementary Fig. 3 ). Mammalian ATG16L1 is therefore an autophagy protein.
We next determined whether markers of autophagy were abnormal in the distal small intestine (ileum, a common site of Crohn's disease) of ATG16L1 HM mice by measuring the expression of ATG16L1, LC3 and P62 proteins in ileal lysates (Fig. 1g-i ). Atg16l1 mRNA is expressed throughout the crypt-villus axis ( Supplementary  Fig. 4 ). ATG16L1 HM mice expressed 23-37% of the expected level of ATG16L1 protein (Fig. 1g, h ). Consistent with a role for ATG16L1 in ileal autophagy, both the ratio of LC3-I to LC3-II and the total amount of LC3-I and P62 were increased in lysates from ATG16L1 HM mice (Fig. 1g, i) . To validate these results, we studied ileal lysates from mice generated by breeding Atg5 flox/flox mice 16 with mice expressing the Cre recombinase under the control of the intestinal-epithelium-specific villin promoter (Atg5 flox/flox villin-Cre mice) 17 . ATG5 expression was diminished in ileal lysates of Atg5 flox/flox villin-Cre mice, and these mice exhibited changes in expression of LC3 and P62 similar to those observed in ATG16L1 HM mice ( Supplementary Fig. 5 ). These data are consistent with a role for ATG16L1 and ATG5 in ileal autophagy.
Deficiency in ATG16L1 had no effect on the overall morphology of the ileum or the colon, as measured by analysis of crypt height or villus length (data not shown). However, there were obvious abnormalities in Paneth cells, leading us to focus our studies on these critically important intestinal innate immune cells. Paneth cells are ileal epithelial cells thought to have a role in control of intestinal microbiota by means of secretion of granule contents including antimicrobial peptides and lysozyme 18 . Staining of whole mounts of ileum revealed the expected co-localization of lysozyme and mucus (Fig. 2a) . However, there was a notable lack of lysozyme staining in the mucus of ATG16L1 HM mice, suggesting an abnormality of Paneth cell secretion (Fig. 2b) . We examined periodic acid-Shiff (PAS)/alcian-blue-stained sections and found extraordinary abnormalities in Paneth cells including aberrant, disorganized granules as well as decreased granule numbers (Fig. 2c, d and data not shown). Blinded analysis of these sections from 7 control and 12 mutant mice revealed a 100% concordance between ATG16L1
HM genotype and abnormal Paneth cell morphology. We quantified these Paneth granule abnormalities by staining sections for lysozyme, which is normally packaged efficiently in the granules 18 ( Fig. 2e-h ). In these sections, we observed a notable population of ATG16L1
HM cells with diffuse lysozyme staining (Fig. 2f, h ). We also observed the presence of intact granules in the crypt lumen of HM1 and ATG16L1 HM2 lines, respectively. WT, wild type. b, MEFs were generated from day 12.5 embryos of Atg16l1 mutant mice, and western blot analysis was used to detect the a and b isoforms of ATG16L1 from whole-cell lysates. c, d, Atg5
2/2 and ATG16L1 HM MEFs were grown in the presence of the chemical inducer of autophagy rapamycin (Rap, 50 mg ml 21 ) and cyclohexamide (CHX, 5 mg ml 21 ) for 0, 4, 8 and 12 h. Cell lysates were analysed by western blot for loss of P62 expression (c). P62 levels were quantified by densitometry normalized to actin (n 5 3; d). *P , 0.04; **P , 0.008; ***P 5 0.0003. e, f, Western blot analysis of LC3 expression in MEFs grown in the presence of rapamycin (50 mg ml
21
) or dimethylsulphoxide (DMSO) control for 4 h (e). LC3-II expression in the presence of rapamycin was quantified and normalized to actin (n 5 6; f). g, Detection of ATG16L1, LC3 and P62 by western blot of ileal lysates from ATG16L1 HM mice. ATG16L1 can be detected in both mutant lines on longer exposures. h, i, Quantification of ATG16L1 (h) and P62 (i) normalized to actin detected in ileal lysates (n 5 3). P values were calculated using two-tailed Student's t-test. Error bars, s.e.m. whole mounts of ileum from ATG16L1 HM mice ( Supplementary Fig.  6a-c) , a finding confirmed by electron microscopy ( Supplementary  Fig. 6d, e) , potentially explaining the absence of lysozyme staining in the mucus layer of the ileum (Fig. 3a, b) . These observations indicate that ATG16L1 is required for maintaining the integrity of the Paneth cell granule exocytosis pathway. On the basis of these data, and the published role for NOD2 in resistance to infection 19 , we orally challenged ATG16L1 HM mice with Listeria monocytogenes. We found no change in L. monocytogenes titres in spleen, liver and mesenteric lymph nodes ( Supplementary Fig. 7) , indicating that the marked changes in release of granules in ATG16L1 HM mice did not affect L. monocytogenes resistance. This argues that the phenotypes of mutations analysed so far in ATG16L1 and NOD2 are distinct.
Despite these profound alterations in the granule exocytosis pathway, we found no evidence for increased epithelial cell death or proliferation, as determined by quantification of apoptotic bodies and 
M-phase cells (not shown). Importantly, deletion of Atg5 in the intestinal epithelium in Atg5
flox/flox villin-Cre mice led to Paneth cell and granule abnormalities similar to those observed in ATG16L1 HM mice ( Fig. 2i and Supplementary Fig. 8 ), whereas other epithelial cells appeared normal. This indicates that, within the ideal epithelium, Paneth cells have a unique sensitivity to autophagy gene disruption.
To characterize better the effects of ATG16L1 deficiency in Paneth cells, we used transmission electron microscopy. We observed degenerating mitochondria, loss of granules and the frequent absence of apical microvilli in ATG16L1 HM Paneth cells (Fig. 3a-e and Supplementary Fig. 6d, e) . Electron microscopy also showed ATG16L1 HM Paneth cells with marked increases in cytoplasmic vesicles (Fig. 3b, d) ; a similar abnormality has been reported in Paneth cells from a Crohn's disease patient 20 . Importantly, such notable findings were not present in epithelial progenitors or enterocytes (Fig. 3b,  d and Supplementary Fig. 9 ), confirming that ATG16L1 deficiency selectively affects Paneth cells within the intestinal epithelium.
We next performed transcriptional profiling of Paneth cell RNA procured by laser capture microdissection (LCM) 21 (see methods and analysis in Supplementary Fig. 10 ). Consistent with a lack of cell death or degeneration, as detected by electron microscopy, microarray analysis revealed that less than 1.5% of probe sets detected changes in RNA levels using low-stringency criteria ($1.3-fold difference; Supplementary Table 1 and Supplementary Fig. 11 ). Cluster analysis of significantly enriched transcripts in ATG16L1-deficient Paneth cells revealed a notable signature of genes involved in peroxisome proliferator-activated receptor (PPAR) pathways, adipocytokine signalling and aspects of lipid metabolism ( Fig. 3f and Supplementary  Fig. 12 ). Additionally, transcripts for several acute-phase reactants including serum amyloid A1, haptoglobin and complement factors D and I were increased (Fig. 3g) . Of particular interest was the observation that the adipocytokines leptin and adiponectin, previously reported to be increased in Crohn's disease patients 4, 5 , were amongst the most highly enriched transcripts (Fig. 3g) .
To determine whether these transcriptional changes are unique to ATG16L1-deficient Paneth cells, we examined a second primary cell type from ATG16L1 HM mice. Autophagy is important in the function of T cells 22 . Thymocytes from ATG16L1 HM mice were normal in number but expressed low levels of ATG16L1 and exhibited decreased conversion of LC3I to LC3II (Supplementary Fig. 13 ), demonstrating that ATG16L1 is important for autophagy in thymocytes. Microarray analysis of these cells revealed that, in marked contrast to Paneth cells, expression of only 27 genes was altered more than 1.3-fold ( Supplementary Fig. 14) . There was no notable change in expression of the most significant clusters of transcripts altered in ATG16L1 HM Paneth cells, and only one gene altered in thymocytes was also altered in Paneth cells (Fig. 3g) . Therefore, the transcriptional signature of ATG16L1 deficiency is specific to Paneth cells, again emphasizing the unique effects of ATG16L1 deficiency on these cells. Taken together with the extensive morphologic abnormalities documented above, we conclude that ATG16L1 deficiency is associated with profound alterations in the specialized properties of Paneth cells including defective granule exocytosis and unexpected increases in expression of genes involved in regulating injury responses.
Given the importance of ATG16L1 and ATG5 in Paneth cells in mice, we examined the role of the human ATG16L1 Crohn's disease risk allele by means of a retrospective analysis of ileocolic resection specimens from patients with Crohn's disease. We studied tissue sections from the uninvolved proximal margins, containing little or no inflammation, from 10 Crohn's disease patients homozygous for the ATG16L1 risk allele compared to 7 Crohn's disease controls without the risk allele. All 17 patients lacked the three major NOD2 risk alleles and the protective IL23R allele for Crohn's disease 7, 23 . Independent blinded examination by T.S.S. and E.M.B. revealed that 100% of at risk patients and 0% of controls contained abnormal Paneth cells, similar to the results in ATG16L1 HM mice (Fig. 4a, b) . We quantified lysozyme staining in Crohn's disease patient specimens, and, like ATG16L1 HM mice, found that patients carrying the ATG16L1 risk allele contained an increased proportion of Paneth cells with disorganized or diminished granules or exhibiting diffuse cytoplasmic lysozyme staining (Fig. 4c-g ). Moreover, consistent with transcriptional analysis in mice, an increased proportion of Paneth cells from at risk patients that exhibited diffuse lysozyme staining D 3 cells in Fig. 4g ) also stained positive for leptin protein compared to similar cells in controls (P , 0.05; Fig. 4e-g ). These findings demonstrate a concordance between the pathology and transcriptional profile of Paneth cells from ATG16L1
HM mice and Paneth cell abnormalities observed in Crohn's disease patients with the risk allele of ATG16L1. , d ) and double-labelled additionally for leptin (green; e, f; yellow dashed line denotes the crypt unit). g, Aberrant lysozyme expression was quantified using the same criteria as that used for mouse sections in Fig. 3 (n 5 6,829 cells for at risk patients and 8,182 for control, n 5 5 patients for each genotype). Leptin-positive D 3 cells were quantified in patient samples (n 5 4 patients per genotype) homozygous for the risk allele (76 out of 322 D 3 cells were positive from a total of 580 crypts examined) and homozygous for the safe allele (11 out of 93 D 3 cells were positive from a total 749 crypts examined). Scale bars: a-f, 10 mm. *P , 0.05, **P , 0.01, ***P , 0.001. P values were calculated using two-tailed Student's t-test. Error bars, s.e.m.
These data indicate that ATG16L1 has a specific role in humans and mice in regulating the specialized properties of Paneth cells, and provide a new and relevant mouse model that emulates one of the many diverse pathological hallmarks of human Crohn's disease. We show that ATG16L1 and a second autophagy protein ATG5 are critically important for the known role of Paneth cells in secretion of granule contents that may alter the intestinal microbiota. In addition, we demonstrate a previously unknown role of ATG16L1 in the regulation of Paneth cell expression of adipocytokines, previously associated with Crohn's disease. Within the intestinal epithelium, the marked effect of autophagy-protein deficiency on Paneth cells, but not on enterocytes, which share a common progenitor, indicates that autophagy can contribute to disease pathogenesis by means of a highly specific role within a single cell lineage. Indeed, the effects of hypomorphic expression of ATG16L1 were specific to Paneth cells and not seen in ATG16L1-deficient thymocytes. An important implication of this type of 'within-lineage' specificity is that future studies will need to focus on how ATG16L1 polymorphisms affect the function of differentiated Paneth cells. Because both environment and genotype have a role in human Crohn's disease pathogenesis 7 , it will be interesting to determine whether environmental triggers including agents that damage the intestine or pathogens alter the pathological features associated with compromised ATG16L1 function.
METHODS SUMMARY
The embryonic stem cell lines BC0122 (ATG16L1
HM1
) and XR0164 (ATG16L1
Hm2
) containing insertions of the gene-trap vector were purchased from Bay Genomics. Founder chimaeric mice were mated with C57BL/6 mice, and heterozygous progenies were mated to each other to generate experimental mice. Littermate mice that are homozygous for the undisrupted allele were used as controls in all experiments.
For immunohistochemistry, paraffin-embedded tissue was washed for 5 min three times with xylene, twice with 100% EtOH, once with 95% EtOH, once with 70% EtOH, and once with PBS. Sections were boiled in Trilogy (Cell Marque) for antigen retrieval, rinsed in deionized water for 15 min, and washed with PBS. Sections were blocked in 1% BSA, 0.3% Triton X-100 PBS, and incubated with a 1:100 dilution of goat polyclonal anti-lysozyme C antibody (C-19), Santa Cruz Biotechnology. The specificity of the antibody was confirmed with a mouse monoclonal anti-lysozyme antibody (BGN/06/961), Abcam. Identical staining was observed when visualized with appropriate secondary antibodies conjugated to Alexa594 (1:500).
For whole-mount immunofluorescence, dissected ileal samples were carefully opened with fine scissors and the intestine was pinned on black wax in 10% buffered formalin for 1 h. The tissue was rinsed three times for 5 min in PBS and incubated with a 1:100 dilution of anti-lysozyme (both mouse and goat antibodies were equivalent) for one hour at 24 uC. After PBS washes, the tissue was incubated with a 1:500 dilution of Cy3-labelled anti-goat or anti-mouse antibody as well as a 1:100 dilution of FITC-labelled H. pomatia lectin for one hour at 24 uC. Tissue was mounted on glass slides after PBS washes and was viewed by an epifluorescence microscope.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
